Humira Side Effects

Generic name: adalimumab

Notification: This document contains details on the Humira Side Effects. Certain dosage forms mentioned on this page might not be applicable to Humira’s brand name. Humira.


Humira Side Effects
Humira Pen

Common adverse effects of Humira are: upper respiratory tract inflammation, headache as well as injection site reactions. the development of antibodies, skin rash as well as sinusitis and discomfort at the injection site.

Other adverse effects include urinary tract infections, abdominal pain or flu-like symptoms. Check out the following list of side effects.

For the Consumer

Humira Side Effects that require immediate medical care

Alongside its necessary results, adalimumab (the active ingredient that is in Humira) could cause undesirable effects. While none of these adverse effects could occur, if they occur, they might require medical attention

Talk to your doctor immediately for any of these adverse reactions that occur when you take Adalimumab:

More common Humira Side Effects

Less well-known Humira Side Effects

The exact cause of Humira Side Effects is not known.

Side effects that do not require immediate medical treatment

Humira Side Effects can occur, but they usually don’t require medical care. These effects can be eliminated when your body adjusts to taking the drug. Additionally, your health care specialist may provide suggestions on ways to reduce or eliminate certain adverse negative effects.

Talk to your doctor for any of these adverse effects persist or become bothersome or If you have questions regarding these side effects:

More commonly

Less well-known


For Healthcare Professionals

It is applicable to adalimumab Subcutaneous kit and subcutaneous solution


Common (1% to 10%): Hypertension

Infrequent (0.1 percent to 1.1%) arrhythmia atrial fibrillation (AF), chest pain coronary artery disorder hypertensive encephalopathy, heart arrest myocardial infarct palpitation, pericardial effusion, , syncope, tachycardia and congestive coronary edema, peripheral deep vein thrombosis

Seldom (less then 0.1 percent) Vascular Occlusion, aortic stenosis or thrombophlebitis aneurysms of the aortic region. Aneurysm of the aortic artery Refer [ Ref


Very frequent (10 percent or more) The most common is Rash (12 percent)

common (1 percent to 10 percent) Eczema, dermatologic pruritus and urticaria. Ecchymosis, ecchymosis and psoriasis bleeding, erysipelas skin vasculitis, herpes zoster

Reports on postmarketing: Stevens-Johnson Syndrome (cutaneous vasculitis), erythema multifforme, new or worsening of psoriasis (all subtypes, including pustular and palmoplantar) Alopecia and erythema multiforme.


Common (0.1 percent to 1.1%) Parathyroid disease 


common (1 percent to 10 percent) Diarrhea and nausea, vomiting, abdominal pain, mouth ulceration, stomatitis

The is a rare (0.1 percent to 1.1%) Cholecystitis, cholelithiasis syndrome, gastroenteritis hemorrhage, gastritis dyspepsia, gastrointestinal disorders, hemorrhage in the gastrointestinal tract, rectal hemorrhage and abdominal bloating.

Seldom (less that 0.1 percent) Esophagitis, intestinal stenosis colitis and enteritis

Frequency not disclosed Large intestinal perforations, perforations related with diverticulitis as well as appendicitis-related appendiceal perforations as well as pancreatitis. 


A common (1 percent to 10 10%) Urinary tract infection and hematuria

Non-common (0.1 percent to 0.1% to) Cystitis, kidney calculus menstrual disorders and pyelonephritis. 


The most common (1 percent to 10 10%) Lymphopenia, Agranulocytosis and leucopenia. anemia, thrombocytopenia and leukocytosis

Rare (less than 0.1%): Pancytopenia, polycythemia, idiopathic thrombocytopenia purpura, lymphoma-like reaction, leg thrombosis, hypertriglyceridemia


Uncommon (0.1 percent to 1 %) Liver failure Hepatitis

Very rare (less that 0.1 percent) Hepatic enzymes are increased and necrosis of the liver

Reports on postmarketing: Hepatic failure


Frequency not disclosed Anaphylaxis, angioneurotic edema 


The common (1 percent to 10 10%)”Flu syndrome”

Uncommon (0.1% to 1%): Sarcoidosis

Frequency not disclosed Autoantibodies are developing.


Very frequent (10 percent or more) Pain at the injection site (12 percent)

Common (1% to 10%): Injection site reaction


Common (1% to 10%): Hypercholesterolemia, hyperlipidemia

Rare (0.1 percent to 0.1% to) Dehydration ketosis and paraproteinemia. increased alkaline-phosphatase


The most common (1 10% to 10 percent) back pain

Uncommon (0.1 to 1% to 0.1% to) Arthritis bone disorder, fracture of the bone (not spontaneously) bone necrosis muscle cramps, joint disorder myasthenia and synovitis, pyogenic arthritis pelvic pain

Very rare (less that 0.1 percent) Rhabdomyolysis 

Nervous system

Very frequent (10 percent or more) Headache (12 percent)

Uncommon (0.1 to 1% to 1.1%) The causes are confusion, paraesthesia Subdural hematoma Tremor, demyelinating disorders (e.g. Guillain-Barre syndrome, optic neuritis) cerebrovascular accident multiple sclerosis

Rare (less then 0.01 percent) Hypertrophic pachymeningitis 


Non-common (0.1 percent to 1.1%) Optic neuritis, cataract 


The is a rare (0.1 percent to 0.1% to): Adenoma, Merkel Cell Carcinoma 

Very rare (less less than 0.1 percent) skin papilloma cancers (breast, the testicular, gastrointestinal, and skin) (melanoma, lymphoma) or cancer of the white blood cells (known as Hepatosplenic T-Cell Lymphoma , or HSTCL) typically in young adults and adolescents. 


Very widespread (10 percent or more) Injury from an accident (10 percent)

Uncommon (0.1 to 1% to 0.1% to) The most common complaint is pain in the extremities Thorax pain

Very Rare (less that 0.1 percent): Pyrexia

Frequency not recorded Sepsis, pain in the thorax or opportunistic infections tuberculosis and histoplasmosis joint infections, abscess, wound infection, fungal infections of the superficial layer 


Frequency not recorded Pain in the kidney and renal impairment 


Very frequent (10 percent or more) The most common causes are upper respiratory infection (17 percent) Sinusitis (11 percent) Pharyngitis, pneumonia and nasopharyngitis.

Common (0.1 percent to 0.1% to) asthma and dyspnea, bronchospasm, dyspnea diminished lung function, an Interstitial lung diseases (including the condition known as pulmonary fibrosis) and pulmonary embolism.

Frequency not disclosed cough, upper respiratory infection Pharyngeal edema, the nasal cavity, pulmonary congestion the pleural effusion and pleurisy 


common (1 10% to 10 percent) (1% to 10%): Changes in mood (including depression) and insomnia, anxiety 

More details

Always consult your doctor to confirm that the information provided on this page is applicable to your particular situation.

Leave a Reply